Author Topic: Increase of Aqueous Tear Volume by Diquafosol Sodium in Patients With Sjogren's  (Read 1075 times)

Jasper

  • Hero Member
  • *****
  • Posts: 1008
  • P SJS; SFN; Sensory Polyneuropathy/Ganglionopathy
From Medscape: New Eyedrops in a pilot study

The Increase of Aqueous Tear Volume by Diquafosol Sodium in Dry-eye Patients With Sj?gren's Syndrome

Abstract

Purpose To investigate the effect of 3% diquafosol sodium ophthalmic solution (DQS) on aqueous tear volume increase in dry-eye patients with Sj?gren's syndrome (SS).

Methods In this pilot study, 17 dry-eye patients with SS (1 male and 16 females; mean age: 66.4 years) were enrolled and underwent topical instillation of two ophthalmic solutions, artificial tears (AT) in one eye and DQS in the fellow eye, in a masked manner. The central lower tear meniscus radius (TMR) curvature was measured before and at 15 min after instillation by video-meniscometry. Simultaneously, all patients self-evaluated their symptoms of wetness and stinging using a visual analog scale (VAS, in millimeters).

Results Topical instillation of DQS significantly increased the TMR at 15 min (mean: 0.21?0.08 (SD) mm) compared with at baseline (mean: 0.16?0.07 mm) (P<0.001, paired t-test), whereas AT had no effect at baseline (mean: 0.18?0.09 mm) or at 15 min (mean: 0.18?0.09 mm). The visual VAS score of wetness at 15-min post-instillation increased in both groups compared with at baseline. In the DQS-treated eyes, the post-instillation change in TMR from baseline was not correlated with the baseline value of the Schirmer test, corneal staining score, or conjunctival staining score.

Conclusions Topical instillation of DQS increased aqueous tear volume on the ocular surface of dry-eye patients with SS, with its action being independent of lacrimal gland function.

Introduction

According to the Dry Eye WorkShop (DEWS) definition, dry eye is a multifactorial disease of the tears and ocular surface that results in symptoms of discomfort, visual disturbance, and tear-film instability with potential damage to the ocular surface. It is accompanied by increased tear-film osmolarity and inflammation of the ocular surface.[1] In addition, the DEWS definition classifies dry eye as either aqueous tear-deficient dry eye or evaporative dry eye. Aqueous tear-deficient dry eye is the type of dry eye typically observed in Sj?gren's syndrome (SS) cases. SS is an organ-specific autoimmune disease[2] and is considered to be associated with decreased tear-fluid secretion from the lacrimal gland and inflammation at the lacrimal gland and the ocular surface.[3?5]

Diquafosol sodium (DQS) ophthalmic solution, which has been approved in Japan for the treatment of dry eye, increases fluid secretion,[6?8] mucin secretion,[9,10] and membrane-binding mucin gene expression on the corneal surface.[11] Reportedly, DQS increases tear-film stability on the ocular surface, thereby improving the subjective symptoms and objective signs of dry eye.[12?15] In addition, DQS exhibits P2Y2 receptor agonist activity and accelerates fluid transport from the serosal to mucosal (tear) side via chloride channel activation following intracellular calcium ion concentration elevation in the conjunctival epithelium.[16,17] The findings of a previous study suggested that the stimulatory action of DQS on fluid secretion is independent of lacrimal gland function, because the Schirmer test results for a rat model of lacrimal gland removal showed aqueous fluid secretion.[6]

Reflective meniscometry is a method used to optically measure the tear meniscus radius (TMR).[18?21] In a previous study, we measured the changes in TMR over time in normal human eyes after instillation of DQS using meniscometry, and reported that there was a significant increase in the fluid volume up until 30 min after the instillation.[8] In this pilot study, we used meniscometry to evaluate the changes in aqueous tear volume after instillation of DQS in patients for whom a definitive diagnosis of SS with dry eye (determined by a Schirmer 1 test value of <10 mm) had been provided, and compared the results with those obtained after instillation of an artificial tear (AT) solution.

Discussion

..... In conclusion, DQS ophthalmic solution has been shown to increase aqueous tear volume on the ocular surface by meniscometry in dry-eye patients with SS with decreased lacrimal gland function. In addition, the results suggest that the stimulatory action of DQS on fluid secretion was independent of lacrimal gland function. Thus, DQS is expected to be an effective treatment for patients with aqueous tear-deficient dry eye with decreased lacrimal gland function, including SS dry eye.
ANA 1:160; SS-A+; MSG +; Plaquenil, Rituxan infusions, Restasis, HRT, Curcumin, Calcium, CoQ10, NAC, Resveratrol, Whole Omega, Omega 3, R Lipoic Acid, Acetyl L Carnitine, Krill Oil, Mag. Threonate, Bio-Collagen UC II, NAD+, & Vit A, B, C, D, E, K 1 & 2.

SunshineDaydream

  • Hero Member
  • *****
  • Posts: 704
Sounds promising. Always good to know researchers are trying to help Sjogren's patients. Thanks for posting.
Sjogren's, lupus, OAB and osteopenia
Rx: Evoxac and Myrbetriq
Vitamins and Supplements: A, B complex, C, D3, E, calcium orotate, magnesium glycinate, D-Mannose, curcumin, fish oil, probiotic

Sharon

  • Hero Member
  • *****
  • Posts: 1301
This is very interesting Jasper!
Wonder when it might be available in countries other than Japan.
Something to look forwards to.
Sjogren's (+ RA?) positive ANA, RNP, RNP-A, APCA salivary gland swelling, dry mouth & eyes,, eyelid swelling & redness, photosensitivity, fatigue, severe joint pain, multiple sensitivities and allergic reactions 
Orencia, Restasis, Paleo Diet, Vit. D & C, Ubiquinol 200mg, Omega 3...

markt

  • Full Member
  • ***
  • Posts: 195
Hi all,

I was curious if their is a clinical trial number associated with this "pilot study"?

It appears this is obviously different from Lacritin or Lacriprep... which I have thrown my name into consideration for trials in FL.

Regards,

Mark


Sharon

  • Hero Member
  • *****
  • Posts: 1301
From what I can tell these eye drops are currently being sold in Japan only.
Perhaps they can be ordered online?
Sjogren's (+ RA?) positive ANA, RNP, RNP-A, APCA salivary gland swelling, dry mouth & eyes,, eyelid swelling & redness, photosensitivity, fatigue, severe joint pain, multiple sensitivities and allergic reactions 
Orencia, Restasis, Paleo Diet, Vit. D & C, Ubiquinol 200mg, Omega 3...

markt

  • Full Member
  • ***
  • Posts: 195
It's a Japanese Trial:

https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018646

From reading the constituent ingredients... it sounds like something a compounding pharmacy could very well fill if your ophthalmologist asked for it.  Who knows...